Guggenheim Capital’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-65,112
| Closed | -$578K | – | 1941 |
|
|
2022
Q4 | $578K | Buy |
65,112
+15,113
| +30% | +$134K | 0.01% | 1414 |
|
|
2022
Q3 | $612K | Sell |
49,999
-13,400
| -21% | -$164K | 0.01% | 1384 |
|
|
2022
Q2 | $750K | Buy |
63,399
+8,739
| +16% | +$103K | 0.01% | 1367 |
|
|
2022
Q1 | $1.04M | Buy |
54,660
+11,891
| +28% | +$226K | 0.01% | 1341 |
|
|
2021
Q4 | $1.14M | Buy |
42,769
+13,628
| +47% | +$362K | 0.01% | 1303 |
|
|
2021
Q3 | $1.2M | Sell |
29,141
-10,552
| -27% | -$433K | 0.01% | 1329 |
|
|
2021
Q2 | $2.25M | Buy |
39,693
+2,524
| +7% | +$143K | 0.01% | 1030 |
|
|
2021
Q1 | $1.56M | Buy |
+37,169
| New | +$1.56M | 0.01% | 1161 |
|
|
2018
Q4 | – | Sell |
-71,863
| Closed | -$2.29M | – | 2216 |
|
|
2018
Q3 | $2.29M | Buy |
71,863
+4,827
| +7% | +$154K | 0.01% | 1166 |
|
|
2018
Q2 | $2.4M | Buy |
67,036
+11,154
| +20% | +$399K | 0.02% | 1138 |
|
|
2018
Q1 | $1.85M | Sell |
55,882
-19,598
| -26% | -$650K | ﹤0.01% | 1692 |
|
|
2017
Q4 | $2.32M | Buy |
+75,480
| New | +$2.32M | 0.01% | 1551 |
|